In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling (Q44982658)

8 December 2017

title

In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling (English)

1 reference

relapsing-remitting multiple sclerosis

8 December 2017

0 references

0 references

author name string

Anya Schneider

1

1 reference

8 December 2017

Sarah Alice Long

2

1 reference

8 December 2017

Karen Cerosaletti

3

1 reference

8 December 2017

Chester T Ni

4

1 reference

8 December 2017

Peter Samuels

5

1 reference

8 December 2017

Mariko Kita

6

1 reference

8 December 2017

Jane Hoyt Buckner

7

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

Science Translational Medicine

8 December 2017

published in

1 reference

8 December 2017

volume

5

1 reference

8 December 2017

issue

170

1 reference

8 December 2017

page(s)

170ra15

1 reference

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Allograft rejection mediated by memory T cells is resistant to regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Physiological and pathological roles of interleukin-6 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004970

10.1126/SCITRANSLMED.3004970

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference